These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12698575)

  • 1. [Efficacy of some new antibiotics in treating experimental brucellosis].
    Maletskaia OV
    Antibiot Khimioter; 2002; 47(11):13-7. PubMed ID: 12698575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis.
    López-Merino A; Contreras-Rodríguez A; Migranas-Ortiz R; Orrantia-Gradín R; Hernández-Oliva GM; Gutiérrez-Rubio AT; Cardeñosa O
    Scand J Infect Dis; 2004; 36(9):636-8. PubMed ID: 15370648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on antimicrobial susceptibility of Brucella in a city].
    Zuo SW; Ni ZL; Yao YB; Yang RS; Wang SK; Zhou YH
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2017 Dec; 35(12):939-941. PubMed ID: 29495161
    [No Abstract]   [Full Text] [Related]  

  • 4. Bactericidal effect of antibiotics on Bartonella and Brucella spp.: clinical implications.
    Rolain JM; Maurin M; Raoult D
    J Antimicrob Chemother; 2000 Nov; 46(5):811-4. PubMed ID: 11062204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroepidemiological and microbiological study of brucellosis in Kuwait.
    Dimitrov Ts; Panigrahi D; Emara M; Awni F; Passadilla R
    Med Princ Pract; 2004; 13(4):215-9. PubMed ID: 15181327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modern chemotherapy for brucellosis in humans.
    Hall WH
    Rev Infect Dis; 1990; 12(6):1060-99. PubMed ID: 2267485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical and biological factors in the control of Brucella and brucellosis.
    Gamazo C; Lecároz MC; Prior S; Vitas AI; Campanero MA; Irache JM; Blanco-Prieto MJ
    Curr Drug Deliv; 2006 Oct; 3(4):359-65. PubMed ID: 17076637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antibacterial activity of tigecycline in comparison with doxycycline, ciprofloxacin and rifampicin against Brucella spp.
    Turan H; Arslan H; Azap OK; Serefhanoğlu K; Uncu H
    Int J Antimicrob Agents; 2007 Aug; 30(2):186-7. PubMed ID: 17462865
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro activity of Brucella melitensis isolates to various antimicrobials in Turkey.
    Denk A; Demirdag K; Kalkan A; Ozden M; Cetinkaya B; Kilic SS
    Infect Dis (Lond); 2015 Jun; 47(6):364-9. PubMed ID: 25712728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of roxithromycin and azithromycin in experimental murine brucellosis.
    Lang R; Shasha B; Ifrach N; Tinman S; Rubinstein E
    Chemotherapy; 1994; 40(4):252-5. PubMed ID: 8082413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of brucellosis using rifampicine (author's transl)].
    Bertrand A; Roux J; Janbon F; Jourdan J; Jonquet O
    Nouv Presse Med; 1979 Nov; 8(44):3635-9. PubMed ID: 534216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftriaxone in the treatment of acute and subacute human brucellosis.
    al-Idrissi HY; Uwaydah AK; Danso KT; Qutub H; al-Mousa MS
    J Int Med Res; 1989; 17(4):363-8. PubMed ID: 2792556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolones for brucellosis: treating old diseases with new drugs.
    Pappas G; Christou L; Akritidis N; Tsianos EV
    Clin Microbiol Infect; 2006 Sep; 12(9):823-5. PubMed ID: 16882286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Resistance in
    Trott DJ; Abraham S; Adler B
    Microbiol Spectr; 2018 Jul; 6(4):. PubMed ID: 30027885
    [No Abstract]   [Full Text] [Related]  

  • 15. Susceptibility of Brucella melitensis to fluoroquinolones.
    Qadri SM; Akhtar M; Ueno Y; al-Sibai MB
    Drugs Exp Clin Res; 1989; 15(10):483-5. PubMed ID: 2632216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of pefloxacin in brucellosis].
    Kurmanova KB; Kkhamfyang S; Iudin SM
    Antibiot Khimioter; 1995 Jul; 40(7):39-42. PubMed ID: 8645059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brucellosis in a dog caused by Brucella melitensis Rev 1.
    Hinić V; Brodard I; Petridou E; Filioussis G; Contos V; Frey J; Abril C
    Vet Microbiol; 2010 Mar; 141(3-4):391-2. PubMed ID: 19828267
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic options for human brucellosis.
    Al-Tawfiq JA
    Expert Rev Anti Infect Ther; 2008 Feb; 6(1):109-20. PubMed ID: 18251668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [E-test susceptibility results of brucella strains for streptomycin, rifampicin, ciprofloxacin and tetracycline].
    Sengöz G; Yaşar KK; Kutlu SB; Durdu YB; Ozdemir R; Nazlican O
    Mikrobiyol Bul; 2006 Jul; 40(3):265-8. PubMed ID: 17001857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tigecycline: its potential for treatment of brucellosis.
    Dizbay M; Kilic S; Hizel K; Arman D
    Scand J Infect Dis; 2007; 39(5):432-4. PubMed ID: 17464866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.